Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Orejudo Macarena, Gómez Manuel J, Riestra Sabino, Rivero Montserrat, Gutiérrez Ana, Rodríguez-Lago Iago, Fernández-Salazar Luis, Ceballos Daniel, Benítez José Manuel, Aguas Mariam, Bastón-Rey Iria, Bermejo Fernando, Casanova María José, Lorente-Poyatos Rufo H, Ber Yolanda, Ginard Daniel, Esteve María, de Francisco Ruth, García María José, Francés Rubén, Rodríguez Ainhoa, Alcaide Suárez Noelia, Guerra Del Río Elena, Soto Pilar, Nos Pilar, Barreiro-de Acosta Manuel, Guerra Iván, Hervías Cruz Daniel, Domínguez Cajal Manuel, Royo Vanesa, Aceituno Montserrat, Aldars-García Laila, Garre Ana, Ramírez Cristina, Soleto Irene, Schuppe-Koistinen Ina, Engstrand Lars, Baldán-Martín Montse, Sánchez-Cabo Fátima, Gisbert Javier P, Chaparro María
Аннотация
METHODS: Microbiota from stool samples were investigated using shotgun metagenomics sequencing and subsequent bioinformatics analysis.
RESULTS: A total of 103 patients with Crohn's disease (CD), 144 with ulcerative colitis (UC), and 49 healthy controls (HC) were included. CD patients had significantly lower species-level diversity than those with UC and HC. CD subgroups with Ileocolonic location and stricturing behavior showed reduced diversity compared to HC. A negative correlation was observed between endoscopic severity and microbial diversity in CD patients. UC patients had similar microbial diversity to HC, which was unaffected by disease activity. Taxonomic abundance analysis revealed a tendency towards a higher relative abundance of Escherichia coli and a lower relative abundance of Faecalibacterium prausnitzii in IBD patients compared to HC. However, the most significant differences in these patients compared to HC were observed in less abundant species, such as Toxoplasma gondii, Gemella morbillorum, and several species of the Adlercreutzia genera. Functional analysis in these patients highlighted changes in carbohydrate and nucleotide pathways.
DISCUSSION: Our data suggest that newly diagnosed CD patients show significant microbiota composition disparities compared to UC patients and HC. Microbiota differences in these patients are linked to dysbiosis, characterized by a reduction in beneficial genera such as Gemella and Adlercreutzia, and a rise in pathogenic species.